Search clinical trials for: Chiauranib

Total 15 results

Akeso
Chipscreen Biosciences, Ltd.

Recruiting

A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

SCLC,Extensive Stage

Australia, China
Chipscreen Biosciences, Ltd.

Recruiting

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Small Cell Lung Cancer

China
Chipscreen Biosciences, Ltd.

Terminated

Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

China
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer (CHIPRO)

Ovarian Cancer | Relapsed or Refractory | Chiauranib | Paclitaxel

China
Chipscreen Biosciences, Ltd.

Completed

Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer

Ovarian Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

Mass Balance Study of [14C]Chiauranib

Small Cell Lung Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Soft Tissue Sarcoma

China
Chipscreen Biosciences, Ltd.

Completed

Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

Solid Tumors

China
Chipscreen Biosciences, Ltd.

Completed

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Small Cell Lung Cancer

China
Chipscreen Biosciences, Ltd.
H & J CRO International, Inc.

Completed

Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers

Healthy Volunteers

China
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. (SCLC)

Small Cell Lung Cancer | Advanced Solid Malignant Tumor

United States
Chipscreen Biosciences, Ltd.

Completed

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Chipscreen Biosciences, Ltd.

Completed

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Ovarian Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC

Triple-negative Breast Cancer

China
Chipscreen Biosciences, Ltd.

Completed

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Non-hodgkin's Lymphoma

China

Search clinical trials for: Chiauranib

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations